Compare Booz Allen Hamilton Holding Corporation (BAH) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Booz Allen Hamilton Holding Corporation vs Heron Therapeutics Inc — how do they compare? Booz Allen Hamilton Holding Corporation trades at $78.41 (market cap $9.45B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Booz Allen Hamilton Holding Corporation is far larger — about 153.7× Heron Therapeutics Inc's market cap, and Booz Allen Hamilton Holding Corporation pays a 3% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BAH | HRTX | |
|---|---|---|
Market Cap | $9.45B | $61.47M |
Sector | Industrials | Health |
52-Week High | $111.63 | $1.49 |
52-Week Low | $59.71 | $0.32 |
Enterprise Value | $13.07B | $168.21M |
Dividend Yield | 3% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Read more on BAH →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
